Edge Pharma, LLC recalls Cantharidin Gel-Forming Suspension, 0.7%, 10 mL per vial, Multiple Dose Vial for Topical Use, Edge Pharma, LLC, 856 Herc
Recalled February 2, 2022 · FDA recall D-0429-2022 · Edge Pharma
Hazard
CGMP Deviations · FDA Class II
Units
1173 vials
Sold at
nationwide
Description
CGMP Deviations
Product
Cantharidin Gel-Forming Suspension, 0.7%, 10 mL per vial, Multiple Dose Vial for Topical Use, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05546 NDC 05446-0572-03
Manufacturer(s)
Edge Pharma, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →